NDC 83301-0010-01 - Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0010
- Requested NDC
- 83301-0010-01
- Package NDCs from labels
- 83301-0010-1, 83301-0010-2, 83301-0010-3, 83301-0010-01
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd.
- Effective date
- 2025-10-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-10-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0010-1 | Metformin Hydrochloride | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 83301-0010-2 | Metformin Hydrochloride | 500 in 1 BOTTLE | TABLET, COATED | 500 | 6 | |
| 83301-0010-3 | Metformin Hydrochloride | 1000 in 1 BOTTLE | TABLET, COATED | 1000 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0010 | METFORMIN HYDROCHLORIDE TABLET, COATED [MULLAN PHARMACEUTICAL INC.] | 4 | Current NDC, 3 package rows | 20240324_082b4de9-e452-fe71-e063-6394a90ac863.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0010-1 | EA - Each | 83301-0010 | 16a38516-a7c6-4f11-a655-118b462e675b | 1 | 2025-07-08 |
| 83301-0010-2 | EA - Each | 83301-0010 | 307aab11-49de-46b6-830e-891e28249164 | 1 | 2025-07-08 |
| 83301-0010-3 | EA - Each | 83301-0010 | 42878dc7-95f7-406b-9955-4ba3dccd61e3 | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METFORMIN HYDROCHLORIDE EXTENDED RELEASE | METFORMIN HYDROCHLORIDE | Proficient Rx LP | f1530d4f-21d9-4a4f-a814-07b180828ecd | 2025-02-01 | Warnings | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Proficient Rx LP | 7cb47c3e-6657-4c11-8aa2-ae172e5a8529 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Lifsa Drugs, LLC | a2385bcd-0943-4411-8658-c22b50360385 | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | RedPharm Drug, Inc. | fc61bafa-a506-14ae-e053-6394a90a9c7d | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE EXTENDED RELEASE | METFORMIN HYDROCHLORIDE | direct rx | a84cf1a3-3820-cd1b-e053-2995a90acf45 | 2025-01-22 | Warnings | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 4adeddf2-f449-4a61-9658-dfbff7c50230 | 2025-01-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin hydrochloride ER | METFORMIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 27d6fdbc-27a8-c599-e063-6394a90a2233 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 0f251f2c-97f3-4048-84f2-81fea03685aa | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Metformin | METFORMIN ER 500 MG | A-S Medication Solutions | fdd3481c-aaec-47ac-9790-01de68b2e253 | 2025-01-09 | Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | TRUPHARMA, LLC | 73691c6c-8841-4c5d-b4a5-c3ed3b5effa1 | 2024-12-27 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | Saptalis Pharmaceuticals, LLC. | df61d56e-18ff-404c-b671-42b39aa23574 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| dapagliflozin and metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Prasco Laboratories | eaf135b6-e378-4f62-a1e7-db45e23668c7 | 2024-12-20 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 286d959a-51cb-4dbd-a3e8-1ea2f00b54c7 | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 289dc8ec-42c8-1d09-e063-6394a90a97f0 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | 5043d03e-3c9d-4c96-b48d-187f02a1d27c | 2024-12-05 | 861010 861004 786Z46389E | |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | bd2e1c06-424b-4222-b723-90ffdcc3983c | 2024-11-30 | 786Z46389E | |
| Metformin HCl | METFORMIN HCL | A-S Medication Solutions | 4ba2a76f-6665-4012-84e4-f2849a0246ac | 2024-11-27 | Warnings, Adverse reactions | 861010 786Z46389E |
| Metformin | METFORMIN ER 750 MG | Bryant Ranch Prepack | f1058475-1318-49a0-89ce-da06692b0e5b | 2024-11-25 | Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 565610b8-a9a0-4e5e-866d-81d9501a817d | 2024-11-15 | Boxed warning, Warnings, Adverse reactions | ANDA205096 861004 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 2d2ebf52-3d5e-4fad-b7f7-c9280957574c | 2024-11-15 | Boxed warning, Warnings, Adverse reactions | ANDA205096 861004 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.